Boston Common Asset Management, LLC Dr Reddys Laboratories LTD Transaction History
Boston Common Asset Management, LLC
- $1.7 Billion
- Q1 2025
A detailed history of Boston Common Asset Management, LLC transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Boston Common Asset Management, LLC holds 53,275 shares of RDY stock, worth $739,457. This represents 0.04% of its overall portfolio holdings.
Number of Shares
53,275
Previous 18,065
194.91%
Holding current value
$739,457
Previous $285,000
146.32%
% of portfolio
0.04%
Previous 0.02%
Shares
17 transactions
Others Institutions Holding RDY
# of Institutions
263Shares Held
106MCall Options Held
71KPut Options Held
22.5K-
Morgan Stanley New York, NY11.3MShares$156 Million0.01% of portfolio
-
Robeco Institutional Asset Management B.V.10.7MShares$149 Million0.28% of portfolio
-
Royal Bank Of Canada Toronto, A610MShares$139 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny9.42MShares$131 Million0.23% of portfolio
-
Aikya Investment Management LTD London, X05.61MShares$77.9 Million36.88% of portfolio
About DR REDDYS LABORATORIES LTD
- Ticker RDY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 166,028,992
- Market Cap $2.3B
- Description
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...